Corvus Pharmaceuticals CRVS
NASDAQ CRVS
$10.90 -0.03 (-0.27%)
At close: Oct 2, 2026 · 4:00 PM EDT

Corvus Pharmaceuticals (CRVS) Short-term Investments (2024 - 2026)

Updated

Corvus Pharmaceuticals (CRVS) reported Short-term Investments of $196.32 million for Q2 2026, down 0.1% from the prior quarter.

Analysis

Corvus Pharmaceuticals (CRVS) Short-term Investments (2024 - 2026) Analysis & Trends

At the end of FY2025, Corvus Pharmaceuticals posted Short-term Investments of $52.17 million, up 20.7% from FY2024.

  • By year, Short-term Investments came in at $43.22 million in FY2024.
  • Five-year quarterly Short-term Investments spans a low of $43.22 million in Q4 2024 and a high of $196.61 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Corvus Pharmaceuticals 919.44 Mn 407.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 196.32 Mn
Mar 31, 2026 196.61 Mn
Dec 31, 2025 52.17 Mn
Dec 31, 2024 43.22 Mn
API Access

Corvus Pharmaceuticals Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=CRVS&period=max&api_key=YOUR_API_KEY